BIOMAT Database Logo BIOMAT Database Logo

Amikacin therapy of serious gram-negative bacillary infections in chronic hemodialysis patients. 1978

R D Meyer, and R P Lewis, and S M Finegold

Amikacin was used to treat 7 serious gram-negative bacillary infections in patients undergoing chronic hemodialysis. 4 were caused by pathogens resistant to gentamicin. 5 infections were cured; 1 was improved and another failed to respond. Mean 1-hour peak serum levels of amikacin ranged from 25.8 to 44.3 microgram/ml. Mean serum levels of amikacin after 6 h of hemodialysis were 61.5% of predialysis levels. Amikacin is highly effective but doses must be reduced in patients requiring hemodialysis and serum levels monitored to avoid ototoxicity.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

R D Meyer, and R P Lewis, and S M Finegold
Netilmicin therapy of serious Gram-negative bacillary infections.
November 1978, The Journal of antimicrobial chemotherapy,
R D Meyer, and R P Lewis, and S M Finegold
Aztreonam therapy for serious gram-negative bacillary infections.
January 1985, Reviews of infectious diseases,
R D Meyer, and R P Lewis, and S M Finegold
Ceftazidime in the therapy of serious Gram-negative bacillary infections.
July 1983, The Journal of antimicrobial chemotherapy,
R D Meyer, and R P Lewis, and S M Finegold
Amikacin therapy for serious gram-negative infection.
February 1977, JAMA,
R D Meyer, and R P Lewis, and S M Finegold
Gram-negative bacillary infections in cancer patients.
December 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R D Meyer, and R P Lewis, and S M Finegold
Generalised gram-negative bacillary infections.
January 1972, Journal of the Royal College of Physicians of London,
R D Meyer, and R P Lewis, and S M Finegold
Immunoprophylaxis of gram-negative bacillary infections.
January 1976, Annual review of medicine,
R D Meyer, and R P Lewis, and S M Finegold
Amikacin in gram-negative paediatric infections.
January 1978, The Journal of international medical research,
R D Meyer, and R P Lewis, and S M Finegold
Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections.
August 1970, Annals of internal medicine,
R D Meyer, and R P Lewis, and S M Finegold
An outbreak of gram-negative bloodstream infections in chronic hemodialysis patients.
January 1995, American journal of nephrology,
Copied contents to your clipboard!